Tesi etd-01032025-112254 |
Link copiato negli appunti
Tipo di tesi
Tesi di specializzazione (4 anni)
Autore
MARCELLO, CRISTINA
URN
etd-01032025-112254
Titolo
Standard vs Personalized Dosimetry in Radioembolization of Primary Liver Tumors: Does It Really Make a Difference?
Dipartimento
RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Corso di studi
RADIODIAGNOSTICA
Relatori
relatore Prof.ssa Crocetti, Laura
Parole chiave
- HCC
- liver
- personalized dosimetry
- radioembolization
- TARE
Data inizio appello
27/01/2025
Consultabilità
Non consultabile
Data di rilascio
27/01/2095
Riassunto
The purpose of this study is to compare the clinical outcomes of two groups of patients with HCC treated with TARE:
Group A: Treated with standard dosimetry.
Group B: Treated with personalized dosimetry.
Personalized dosimetry leverages advanced imaging techniques, such as SPECT/CT with 99mTc-MAA, to segment tumor and liver volumes accurately. This enables tailored radiation delivery, maximizing tumor dose while sparing healthy liver tissue
Group A: Treated with standard dosimetry.
Group B: Treated with personalized dosimetry.
Personalized dosimetry leverages advanced imaging techniques, such as SPECT/CT with 99mTc-MAA, to segment tumor and liver volumes accurately. This enables tailored radiation delivery, maximizing tumor dose while sparing healthy liver tissue
File
| Nome file | Dimensione |
|---|---|
Tesi non consultabile. |
|